The establishment of specific reference intervals for serum transthyretin tetramer, misfolded proteins, and protein misfolding rate and its application in evaluating transthyretin amyloidosis patients
Tingting Wang , Ming Wu , Ying Wang , Ying Li , Xueting Cui , Xiaoyu Sun , Qiuhua Yu , Yunfeng Cao , Yu Liu , Zhuang Tian
{"title":"The establishment of specific reference intervals for serum transthyretin tetramer, misfolded proteins, and protein misfolding rate and its application in evaluating transthyretin amyloidosis patients","authors":"Tingting Wang , Ming Wu , Ying Wang , Ying Li , Xueting Cui , Xiaoyu Sun , Qiuhua Yu , Yunfeng Cao , Yu Liu , Zhuang Tian","doi":"10.1016/j.cca.2025.120218","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>To accurately assess disease risk, specific reference intervals for transthyretin (TTR) tetramers, misfolded proteins, and protein misfolding rates are essential. This study aimed to establish reference intervals using a robust and traceable ultrahigh performance liquid chromatography (UPLC) method and to evaluate the distribution of these biomarkers in patients with transthyretin amyloidosis (ATTR).</div></div><div><h3>Methods</h3><div>Serum samples from 331 healthy Chinese individuals were included. Participants were stratified into two age groups: <60 years and ≥ 60 years. The reference intervals were determined following the Clinical and Laboratory Standards Institute (CLSI) EP28-A3.</div></div><div><h3>Results</h3><div>The established reference intervals for TTR tetramers, misfolded proteins, and protein misfolding rates revealed significant age- and sex-specific variations. In the < 60 years age group, the TTR tetramer reference intervals were 3.01–6.30 μmol/L for males and 2.62–5.39 μmol/L for females. Corresponding reference intervals for misfolded proteins were 0.24–1.43 μmol/L for males and 0.33–1.39 μmol/L for females, with protein misfolding rate upper limits of 26.32 % and 27.47 %, respectively. In the ≥ 60 years age group, TTR tetramer reference intervals from 2.56–5.48 μmol/L for males and 2.36–5.10 μmol/L for females. Misfolded protein reference intervals were 0.28–2.03 μmol/L for males and 0.29–1.59 μmol/L for females, while protein misfolding rate upper limits were 33.69 % for males and 30.64 % for females.</div></div><div><h3>Conclusions</h3><div>This study successfully established detailed, age- and sex-specific reference intervals for TTR tetramers, misfolded proteins, and protein misfolding rates, providing valuable references for clinical practice and further investigations into disease risk associated with TTR biomarkers.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"571 ","pages":"Article 120218"},"PeriodicalIF":3.2000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S000989812500097X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
To accurately assess disease risk, specific reference intervals for transthyretin (TTR) tetramers, misfolded proteins, and protein misfolding rates are essential. This study aimed to establish reference intervals using a robust and traceable ultrahigh performance liquid chromatography (UPLC) method and to evaluate the distribution of these biomarkers in patients with transthyretin amyloidosis (ATTR).
Methods
Serum samples from 331 healthy Chinese individuals were included. Participants were stratified into two age groups: <60 years and ≥ 60 years. The reference intervals were determined following the Clinical and Laboratory Standards Institute (CLSI) EP28-A3.
Results
The established reference intervals for TTR tetramers, misfolded proteins, and protein misfolding rates revealed significant age- and sex-specific variations. In the < 60 years age group, the TTR tetramer reference intervals were 3.01–6.30 μmol/L for males and 2.62–5.39 μmol/L for females. Corresponding reference intervals for misfolded proteins were 0.24–1.43 μmol/L for males and 0.33–1.39 μmol/L for females, with protein misfolding rate upper limits of 26.32 % and 27.47 %, respectively. In the ≥ 60 years age group, TTR tetramer reference intervals from 2.56–5.48 μmol/L for males and 2.36–5.10 μmol/L for females. Misfolded protein reference intervals were 0.28–2.03 μmol/L for males and 0.29–1.59 μmol/L for females, while protein misfolding rate upper limits were 33.69 % for males and 30.64 % for females.
Conclusions
This study successfully established detailed, age- and sex-specific reference intervals for TTR tetramers, misfolded proteins, and protein misfolding rates, providing valuable references for clinical practice and further investigations into disease risk associated with TTR biomarkers.
期刊介绍:
The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.
The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.